• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Abilify

Abilify

February 1, 2003
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

J.C. Michael Shea is Supervising Psychiatrist at Health and Education Services in Haverhill Massachusetts, and has treated many thousands of schizophrenic patients over a 30 year career. He has definitely hopped onto the Abilify bandwagon, and his perspective is an interesting one.

“I’ve put 20 people on Abilify, and I actually consider it to be as good an antidepressant as an antipsychotic. The first patient I put on Abilify was a woman with chronic undifferentiated schizophrenia, who had been stably unstable for many years. She had been on Mellaril for years, then was switched to Zyprexa, and was doing fairly well. One day she came to me and told me her primary care physician had put her on an anti-hyperglycemic medication and had diagnosed her with diabetes. She was quite overweight, and so she was switched to Geodon. Her blood sugar fell, and then we were able to eliminate her diabetic medication. Unfortunately, she started to complain that she didn’t like the way Geodon made her feel. It appeared to be akathisia. I started her on Inderal, but she had made up her mind—she didn’t like Geodon. In our patients, you don’t get a second chance! So she was started on Abilify 15 mg a day. Exactly three weeks later, on January 2 of this year, she came in, and said, “Doc, what have you done to me, you’ve made me horny!” I said, “Happy New Year, you get a twofer with this drug!” She was brighter in terms of her mood, her libido had improved, and no, she wasn’t manic, though I may have seen hypomania in one other patient on Abilify.
General Psychiatry
    www.thecarlatreport.com
    Issue Date: June 1, 2008
    SUBSCRIBE NOW
    Table Of Contents
    Abilify
    Dr. Michael Jibson on Choosing Among Atypicals
    Atypicals: Do they work for Depression?
    Abilify: The Perfect Antipsychotic?
    The Trouble with Zyprexa
    The First Antipsychotic
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.